The expression and activity of CYP1A1 were examined in fresh, small-sized l
ung biopsy specimens from nine human subjects. CYP1A1 transcripts were dete
cted by reverse transcription-polymerase chain reaction (RT PCR) analysis o
f total lung RNA. CYP1A2 transcripts were detected in the RNA samples as we
ll, and bioactivation of 2-aminofluorene: (2-AF) or 2-amino-3,4-dimethylimi
dazo[4.5-f]quinoline (MelQ), a CYP1A2-preferential activity, was catalyzed
by the lung S-9 fractions also. Two major bands were detected in the whole
homogenate by western blot analysis using CD3, a mouse anti rat CYP1A1 mono
clonal that cross-reacts with rat CYP1A2 as well as with human CYP1A1 and C
YP1A2. S-9 fractions from the tissues catalyzed the bioactivation of benzo[
a]pyrene (B[a]P). a CYP1A1-preferential activity, to mutagens in the Ames a
ssay. Our findings are in agreement with the known presence of CYP1A1 in th
e human lung. and provide strong evidence for the expression of catalytical
ly functional CYP1A2 in the tissue. (C) 2001 Elsevier Science Ireland Ltd.
All rights reserved.